Your browser doesn't support javascript.
loading
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.
Oji, Yusuke; Hashimoto, Naoya; Tsuboi, Akihiro; Murakami, Yui; Iwai, Miki; Kagawa, Naoki; Chiba, Yasuyoshi; Izumoto, Shuichi; Elisseeva, Olga; Ichinohasama, Ryo; Sakamoto, Junichi; Morita, Satoshi; Nakajima, Hiroko; Takashima, Satoshi; Nakae, Yoshiki; Nakata, Jun; Kawakami, Manabu; Nishida, Sumiyuki; Hosen, Naoki; Fujiki, Fumihiro; Morimoto, Soyoko; Adachi, Mayuko; Iwamoto, Masahiro; Oka, Yoshihiro; Yoshimine, Toshiki; Sugiyama, Haruo.
Afiliación
  • Oji Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hashimoto N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tsuboi A; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Murakami Y; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iwai M; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kagawa N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Chiba Y; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Izumoto S; Department of Neurosurgery, Kinki University, Osaka, Japan.
  • Elisseeva O; Cell Signal Unit, Okinawa Institute of Science and Technology, Okinawa, Japan.
  • Ichinohasama R; Department of Hematology, Tohoku University, Miyagi, Japan.
  • Sakamoto J; Tokai Central Hospital, Aichi, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nakajima H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takashima S; Respiratory Medicine and Allergy, Rheumatic Disease, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nakae Y; Respiratory Medicine and Allergy, Rheumatic Disease, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nakata J; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Kawakami M; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Nishida S; Respiratory Medicine and Allergy, Rheumatic Disease, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Hosen N; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Fujiki F; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Morimoto S; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Adachi M; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iwamoto M; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Oka Y; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Yoshimine T; Respiratory Medicine and Allergy, Rheumatic Disease, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Sugiyama H; Department of Immunopathology, Immunology Frontier Research Center (World Premier International Research Center), Osaka University, Osaka, Japan.
Int J Cancer ; 139(6): 1391-401, 2016 Sep 15.
Article en En | MEDLINE | ID: mdl-27170523

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Inmunoglobulina G / Glioblastoma / Vacunas contra el Cáncer / Proteínas WT1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Péptidos / Inmunoglobulina G / Glioblastoma / Vacunas contra el Cáncer / Proteínas WT1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Japón